Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia
NCT07311343Phase 4Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of ceftazidime, chlorhexidine in pneumonia, sponsored by Beijing Tiantan Hospital. Started Jan 2026; status: recruiting.
02
Drugs
ceftazidimechlorhexidine
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT07311343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07311343.